1. Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin

   • Tim Eisen
   • Gunnar Hedlund
   • Robert Hawkins

   Evolving Therapies (R Bukowski, Section Editor) Open access 21 January 2014 Article: 370

   

2. Endoscopic Resection of Sinonasal Cancers

   • Shirley Y. Su
   • Michael E. Kupferman
   • Ehab Y. Hanna

   Head and Neck (E Hanna, Section Editor) 21 January 2014 Article: 369

3. Aflibercept—a Decoy VEGF Receptor

   • Kristen K. Ciombor
   • Jordan Berlin

   Evolving Therapies (R Bukowski, Section Editor) 21 January 2014 Article: 368

4. Etirinotecan Pegol: Development of a Novel Conjugated Topoisomerase I Inhibitor

   • Carlos Alemany

   Evolving Therapies (R Bukowski, Section Editor) 21 January 2014 Article: 367

5. Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter?

   • Daniel M. Halperin
   • Gauri R. Varadhachary

   Gastrointestinal Cancers (B Czito, Section Editor) 21 January 2014 Article: 366

6. Endoglin for Targeted Cancer Treatment

   • Lee S. Rosen
   • Michael S. Gordon
   • Daniela E. Matei

   Evolving Therapies (R Bukowski, Section Editor) 21 January 2014 Article: 365

   

7. Timing of Determining Axillary Lymph Node Status When Neoadjuvant Chemotherapy is Used

   • Eleftherios P. Mamounas

   Breast Cancer (B Overmoyer, Section Editor) 21 January 2014 Article: 364